Stratagene Questions Logic of Jury Award, Says Injunction Will Not Affect Its Dx Plans | GenomeWeb

Despite an injunction issued last week that prevents Stratagene from selling its FullVelocity QPCR and QRT-PCR products, company officials intend to press ahead with their plans to enter the molecular diagnostics market while appealing an earlier judgment against the company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.